CARB-X makes first grants to spur development of new antibiotics
An international partnership created to encourage development of new antimicrobials and diagnostics awarded $24 million to scientists pursing 11 projects with an additional $24 million possible over three years, if the researchers make progress. It was the first round of money from the Combating Antibiotic Resistant Bacteria Accelerator (CARB-X), formed last July with a goal of investing $450 million over five years.